Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424554
Status:
COMPLETED
Last Update Posted:
2017-06-07
First Post:
2007-01-18
Brief Title:
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas P04602 AM1 Completed
Sponsor:
Organization:
Merck Sharp Dohme LLC